Michael L. Meyers

Companies

• Nuvalent, Inc.Board member Oct 6, 2022 to now¹
• Syndax Pharmaceuticals IncSVP, Chief Development Officer Mar 2, 2016 to Feb 3, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SPSyndax Pharmaceuticals Inc SNDX23,280 shares³$303.9K at $13.05Jan 31, 2022
• NNuvalent, Inc.0 shares⁴Jul 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Returned to company 3,444 shares of Nuvalent, Inc.⁴
• Jul 15, 2026U 5,146 shares at $124.00 of Nuvalent, Inc.⁴
• Jun 16, 2026Granted 3,444 shares of Nuvalent, Inc.⁵
• Jun 18, 2025Granted 2,647 shares of Nuvalent, Inc.⁶
• Jun 12, 2024Granted 2,499 shares of Nuvalent, Inc.⁷
• Jan 31, 2022Other 1,714 shares at $12.39 of Syndax Pharmaceuticals Inc³
• Dec 30, 2021Exercised options 5,900 shares at $8.77 of Syndax Pharmaceuticals Inc⁸